Biocartesian
Biocartesian combines microscopy and chemistries to detect molecules in tissues, providing insights into disease biology and therapies.
Source: ycombinator.com
Funding history ↓Signals
Website registeredDec 26, 2022 (3 years old)
Funding rounds
- Website created
- Date unknownRound · $500K*Source: ycombinator.com
Founders and team
ID
Ian Dardani, PhD Co-founder & CEOLinkedIn · source: foundertrace.comJL
Jessica Li Co-founder & CSOLinkedIn · source: foundertrace.com
Investors
Companies like Biocartesian
MMirador Therapeutics$250M Series B+ · Jan 2026
CCity TherapeuticsSeries B+ · Aug 2026
RRougeTx$58M Series A · Oct 2026
RRevier Therapeutics$6.95M Seed · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
AAlzheon$100M Series B+ · Apr 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/biocartesian (get a free API key).